| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |